CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological CharacterizationA. R. English, Wayne E. Barth, James A. Retsema et al.|Antimicrobial Agents and Chemotherapy|1978Cited by 397
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distributionAgnès Girard, James A. Retsema, D Girard et al.|Antimicrobial Agents and Chemotherapy|1987Cited by 323
Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.G. Michael Bright, Rachel J. Mason, A. R. English et al.|The Journal of Antibiotics|1988Cited by 238
Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute InfectionJames A. Retsema, Perry S. Sawyer, A. R. English et al.|Clinical Infectious Diseases|1986Cited by 106
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and BacteroidesJames A. Retsema, Agnès Girard, A. R. English|Antimicrobial Agents and Chemotherapy|1980Cited by 82